RANTES as a Novel Biomarker for Atherogenic Dyslipidemia and Metabolic Disturbances in Patients with Type-2 Diabetes | ||
| Egyptian Society of Diabetes and Lipidology Journal | ||
| Volume 3, Issue 2, October 2023 PDF (792.79 K) | ||
| Document Type: Abstracts | ||
| DOI: 10.21608/esdlj.2023.456210 | ||
| Abstract | ||
| RANTES (Regulated upon Activation, Normal T cell Expressed and presumably Secreted) is a chemokine engaged in the pathophysiology of diabetes type 2 (T2DM), related cardiovascular complications, dyslipidemia and hypertension that are major modifiable risk factors of T2DM. VEGF (Vascular endothelial growth factor) plays a role in diabetic vascular complications. | ||
|
Statistics Article View: 1 |
||
